Skip to main content

Analytical White Papers

Free analytical and research White Papers on the topic of reimbursement, HTA and evidence requirements for medical devices and IVD tests in Europe

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Dutch Organization for Health Research and Development awarded five projects under HTA Methodology Program for 2021-2024

To give researchers more tools to assess healthcare innovations' efficiency and demonstrate the effectiveness of novel technologies, the Dutch Organization for Health Research and Development (ZonMw), in collaboration with the National Health Care Institute (ZIN), initiated the HTA Methodology Program for 2021-2024.

From July 12, 2023, until October 03, 2024, ZonMw announced the submission of grant applications to develop a methodology for assessing technologies used in non-curative care to determine the value of technology. A total of €1.3 million was available, with a maximum amount of €200,000 per project for 24 months. 

The following five projects were awarded subsidies under this round:

  • A new standard for assessing Mental Health QoL for youth: development and validation of the Mental Health Quality of Life-Youth (MHQoL-Y) questionnaire;
  • Development of a multi-stakeholder outcome measure for the value of remote patient management;
  • Measuring quality of life in people with dementia: which questionnaire and who completes it?
  • PROPr Dutch: Developing a country-specific value set for the PROMIS preference system;
  • W-MIC: multi-instrument comparison study for well-being measurement in the Netherlands

See more information in Dutch here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.